A new approach to delay the development of resistance to docetaxel in the treatment of castration-refractory prostate cancer.
S. Filleur
No relevant relationships to disclose
S. R. Sennoune
No relevant relationships to disclose
J. C. Lees
No relevant relationships to disclose
J. Hirsch
No relevant relationships to disclose
L. Bermudez
No relevant relationships to disclose
R. Martinez-Zaguilan
No relevant relationships to disclose
T. Nelius
No relevant relationships to disclose